Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
DARE
— Dare Bioscience, Inc.
NASDAQ
FULL STOCK PAGE →
Q4 2025 Earnings Call Summary
MAR 26, 2026
REVENUE
$1.0M
+45155.3%
NET MARGIN
-140.8%
+157364.3 PTS
EPS
-$0.10
+64.5%
FREE CASH FLOW
$1.2M
+300.6%
No summary has been written for this call yet.
← NEWER CALL
CALL 3 OF 4
OLDER CALL →